Pharmacology and Toxicology of Proteins by Ford, James M.
478 BOOK REVIEWS
good job of summarizing older important concepts and of bringing the reader up to
date on current research trends in aneuploidy.
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One of the most promising and practical applications resulting from the enormous
advances made in the understanding of molecular structure and biology of proteins is
in the area of therapeutics and drug development. While recombinantly produced
protein and peptide drugs offer the possibility for extremely specific and potent
pharmaceuticals for the modulation of biological responses, the toxicology of only a
few ofthese novel agents has been rigorously studied. This collection ofpapers from a
recent UCLA symposium sponsoredjointly by Cetus Corporation is devoted primarily
to a discussion of the unique problems now being encountered in the analysis of the
pharmacokinetics, metabolism, immunogenicity, and toxicology of proteins and pep-
tides. Specifically, the clinical pharmacology of monoclonal antibodies, interleukin-2,
interferons, protease inhibitors, and thrombolytics are examined, as well as novel drug
delivery systems particularly suited to these experimental therapies.
Unfortunately, this volume, like so many of these hastily edited collections, is a
disparate, incohesive, and largely superficial group of descriptive papers. While there
are a few valuable contributions, such as the thorough review of monoclonal antibody
therapies for infectious diseases, this book suffers most notably from the lack ofpapers
devoted to toxicological testing of gene products (attributed by one speaker to the
concurrent Society ofToxicology Meeting!).
The clinical pharmacology of proteins and peptides represents a fascinating and
largely uncharted subject, which will undoubtedly gather increased attention from
both the medical and scientific communities as new drugs near clinical trials. This
volume, however, serves as neither a balanced review nor an appropriate introduction
to this subject. Industrial toxicologists may find their colleagues' discussions interest-
ing and somewhat valuable, but the student or clinician interested in protein
therapeutics is advised to continue reading the primary literature for now.
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Developmental models have long played a significant role in neurology. Recently,
however, there also has been increased interest among biological psychiatrists in the
neurodevelopmental processes which regulate the onset, course, and offset of illnesses
such as schizophrenia and anxiety disorders. In Neural Plasticity: A Lifespan
Approach, the thirty-sixth volume in the "Neurology and Neurobiology" series from
Alan R. Liss, Inc., leading researchers in the developmental neurosciences review
recent progress in three principal areas: (1) early cortical development, (2) transplanta-
tion of neural tissue, and (3) senescent developmental changes.